A computational model for classification of BRCA2 variants using mouse embryonic stem cell-based functional assays
Abstract Sequencing-based genetic tests to identify individuals at increased risk of hereditary breast and ovarian cancers have resulted in the identification of more than 40,000 sequence variants of BRCA1 and BRCA2. A majority of these variants are considered to be variants of uncertain significanc...
Guardado en:
Autores principales: | Kajal Biswas, Gary B. Lipton, Stacey Stauffer, Teresa Sullivan, Linda Cleveland, Eileen Southon, Susan Reid, Valentin Magidson, Edwin S. Iversen, Shyam K. Sharan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/040ac1e333f54a36a947eae448e108dd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
por: Xia Ding, et al.
Publicado: (2016) -
WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells
por: Arindam Datta, et al.
Publicado: (2021) -
BRCA locus-specific loss of heterozygosity in germline BRCA1 and BRCA2 carriers
por: Kara N. Maxwell, et al.
Publicado: (2017) -
Classifications within molecular subtypes enables identification of BRCA1/BRCA2 mutation carriers by RNA tumor profiling.
por: Martin J Larsen, et al.
Publicado: (2013) -
Sirtuin inhibition is synthetic lethal with BRCA1 or BRCA2 deficiency
por: Ilirjana Bajrami, et al.
Publicado: (2021)